Lifecore Biomedical Inc (LFCR)
7.31
+0.33
(+4.73%)
USD |
NASDAQ |
Nov 22, 16:00
7.29
-0.02
(-0.27%)
Pre-Market: 20:00
Lifecore Biomedical Cash from Financing (Quarterly): 1.093M for Aug. 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 1.093M |
| May 31, 2024 | -0.614M |
| February 29, 2024 | 7.637M |
| November 30, 2023 | -2.448M |
| August 31, 2023 | 2.934M |
| May 31, 2023 | 24.57M |
| February 28, 2023 | 2.414M |
| November 30, 2022 | 8.809M |
| August 31, 2022 | 3.906M |
| May 31, 2022 | 19.14M |
| February 28, 2022 | -47.09M |
| November 30, 2021 | 9.878M |
| August 31, 2021 | -38.95M |
| May 31, 2021 | 6.988M |
| February 28, 2021 | 11.59M |
| November 30, 2020 | -4.972M |
| August 31, 2020 | -17.02M |
| May 31, 2020 | 15.02M |
| February 29, 2020 | -6.077M |
| November 30, 2019 | 15.06M |
| August 31, 2019 | 16.02M |
| May 31, 2019 | 5.211M |
| February 28, 2019 | 61.60M |
| November 30, 2018 | 1.491M |
| August 31, 2018 | 10.72M |
| Date | Value |
|---|---|
| May 31, 2018 | 8.605M |
| February 28, 2018 | 0.60M |
| November 30, 2017 | -2.114M |
| August 31, 2017 | 6.201M |
| May 31, 2017 | 2.126M |
| February 28, 2017 | -2.796M |
| November 30, 2016 | -2.518M |
| August 31, 2016 | -5.613M |
| May 31, 2016 | 0.884M |
| February 29, 2016 | 9.011M |
| November 30, 2015 | 7.391M |
| August 31, 2015 | -1.863M |
| May 31, 2015 | -7.65M |
| February 28, 2015 | 2.844M |
| November 30, 2014 | 7.071M |
| August 31, 2014 | 5.441M |
| May 31, 2014 | -1.261M |
| February 28, 2014 | 0.191M |
| November 30, 2013 | -0.847M |
| August 31, 2013 | -5.262M |
| May 31, 2013 | -1.886M |
| February 28, 2013 | -2.915M |
| November 30, 2012 | -0.038M |
| August 31, 2012 | -14.43M |
| May 31, 2012 | 39.21M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-47.09M
Minimum
Feb 2022
24.57M
Maximum
May 2023
0.5932M
Average
3.42M
Median
Cash from Financing (Quarterly) Benchmarks
| AngioDynamics Inc | -0.509M |
| Precision Optics Corp Inc | 0.577M |
| Sage Therapeutics Inc | 1.037M |
| Outset Medical Inc | 0.121M |
| NovaBay Pharmaceuticals Inc | 2.089M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.643M |
| Cash from Investing (Quarterly) | -3.392M |
| Free Cash Flow | -8.79M |
| Free Cash Flow Per Share (Quarterly) | -0.1308 |
| Free Cash Flow to Equity (Quarterly) | -10.68M |
| Free Cash Flow to Firm (Quarterly) | 1.325M |
| Free Cash Flow Yield | -3.41% |